Aesthetics

Speaking at the 2022 Fall Clinical Dermatology Conference for PAs & NPs, Joshua Zeichner, MD, cut through marketing hype and misperceptions of patients to assess products that bridge cosmetics and medicine.

In this month's Cosmetic Conundrums, Zoe Diana Draelos, MD, tackles the issues of hair loss after pregnancy, the role of pH in hair care, hair strengthening conditioner, and more.

Each month, Dermatology Times® features a roundup of products trending in skin care. Click here to find out what products are trending for the month of May.

A Portuguese study examined the association between the use of anti-aging products and the self-esteem of the women who used them.

Hello There <i>Yo</i>

This week's edition of the Mainstream Patients features stories about treating scars, jojoba oil for skin, and more.

Aging in skin of color is less about wrinkling and more about fat loss.

“Medical literature from India and the Middle East is full of reports of success in treating postinflammatory hyperpigmentation and melasma with topical tranexamic acid, but properly powered, well-controlled studies are still lacking.”

Ilanit Samuels, PA-C, talks the future of aesthetics and the trends she sees while treating her patients at the Florida Society of Dermatology Physician Assistants 2022 New Wave Dermatology Conference.

IIanit Samuels, PA-C, of Illy Aesthetics, discusses the importance of thorough injectable training.

Tanya Patron, PA-C, the owner and founder of the Selfie Aesthetic, gave an important talk on neurotoxins at the 2022 New Wave Dermatology Conference in Coral Gables, Florida.

Theodore Rosen, MD, highlights the need for communication with patients about the potential harm of using skin-whiteners.

In this month’s “Meet the Aesthetic Expert” column, Will Kirby, DO, FAOCD, talks with Collin M. Blattner, DO, FAAD, about perspective-changing complications, the future of aesthetic conferences, and the importance of allied health care providers.

Veronica Richardson, MSN, ANP-BC, DCNP, discussed how she diagnoses hair loss subtypes in her session at the 3rd Annual Society of Dermatology Nurse Practitioners Symposium.

Revance Therapeutics announces the FDA has accepted the resubmission for daxibotulinumtoxinA for injection of glabellar lines.

Chinese patients with moderate to severe crow’s feet lines reported high levels of satisfaction with onabotulinumtoxinA treatment, according to a recently published study.

A comprehensive review explored new uses of this popular technology in aesthetic and medical dermatology.

Arcutis Biotherapeutics announced news of its topical roflumilast foam’s trial on safety and efficacy of treatment in scalp and body psoriasis.

In this week’s Pointers with Dr Portela, the 208SkinDoc lists the top 5 ingredients to look for when patients are choosing over the counter solutions.

In this video interview, Darren Smith, MD, comments on the Renuvion/J-Plasma device (Apyx Medical) receiving an FDA warning for dermal resurfacing or skin contraction. He dives into how the device may be causing these issues, how this affects patients, and more.

A multicenter investigation provides information on the prevalence and incidence of alopecia areata in children.

“Microneedling has been touted to the consumer as a means to enhance the penetration of moisturizers, vitamins, skin-lightening ingredients, and other cosmeceuticals. Is this enhanced penetration good? It depends.”

In this week’s Pointers with Dr Portela, the 208SkinDoc highlights alopecia, discussing the different types, and the emotional impact of hair loss.

Dermatology Times® invites medical professionals in the dermatology community to speak out on the vital issues facing the specialty.

The company reported positive results from the PEARL-1 clinical phase 1 study regarding KB301 as an investigational gene-based treatment to address the underlying biology of aging skin.